Table 1. STR profile of patients and PDTXs.

	AMEL	D5S818	D13S317	D7S820	VWA	TH01	TPOX	CSF1P0	D18S51	D3S1358	D8S1179	FGA
patient 16	XY	12,13	13,14	8	18,19	8,9.3	11,12	12	14	16,18	12,15	21,22
Mela16 PDTX	XY	12,13	13,14	8, 11	18,19	8,9.3	11,12	12	14	16,18	12,15	21,22
patient 11	XY	11,12	11,12	10	18,19	7,9.3	8	10,12	13,17	16	13,*	21
Mela11 PDTX	XY	11,12	11,12	10	18,19	7,9.3	8	10,12	13,17	16	13,14	21
patient 14	XY	12	11,12	9,11	16,20	9,9.3	8	10,12	10.1,14	*,16	12,14	24,26
Mela14 PDTX	XY	12	11,12	9,11	16,20	9,9.3	8	10,12	10.1,14	15,16	12,14	24,26

STR DNA sequences of both patient and mouse tumors validate genetic identities of developed models. a, Asterisks indicated lost allele.